Article
Retrospective analysis of safety and feasibility of a 3 days on/11 days off temozolomide dosing regimen in recurrent adult malignant gliomas
CNS oncology
(2014)
Disciplines
Publication Date
July 1, 2014
DOI
10.2217/cns.14.29
Citation Information
Vincent A van Vugt, David E Piccioni, Bradley D Brown, Tiffany Brown, et al.. "Retrospective analysis of safety and feasibility of a 3 days on/11 days off temozolomide dosing regimen in recurrent adult malignant gliomas" CNS oncology Vol. 3 Iss. 4 (2014) p. 257 - 265 Available at: http://works.bepress.com/marlon-saria/30/